Bone marrow and bone: a functional unit.

Bone and bone marrow, although often regarded as separate systems, function as a single unit. Cells in the bone marrow are the precursors of bone remodelling cells and exert an important regulatory role both on their own development and the remodelling process, acting as mediators for the effects of systemic and local factors. Other cells, such as immune cells and megakaryocytes, also contribute to the regulation of bone cell development and activity. Many diseases that affect the bone marrow have profound effects on bone, involving interactions between abnormal and normal marrow cells and those of bone. Although recent advances in bone physiology have produced new insights into the relationship between bone marrow and bone cells, much remains to be learnt about the mechanisms by which marrow and bone act in synergy to regulate bone remodelling, both in health and disease.

[1]  R. Kimble,et al.  Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy. , 1993, The Journal of clinical endocrinology and metabolism.

[2]  J. Compston,et al.  Mechanisms by which high-dose estrogen therapy produces anabolic skeletal effects in postmenopausal women: role of locally produced growth factors. , 2001, Bone.

[3]  N. Udagawa,et al.  Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. , 1993, The Journal of clinical investigation.

[4]  D. Thompson,et al.  Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. , 1994, Endocrinology.

[5]  J. Compston,et al.  Megakaryocyte population in human bone marrow increases with estrogen treatment: a role in bone remodeling? , 2000, Bone.

[6]  L. Avioli,et al.  Heparin-induced osteopenia: an appraisal. , 1975, Advances in experimental medicine and biology.

[7]  T. Bringman,et al.  Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. , 1987, The New England journal of medicine.

[8]  J. Caffey Cooley's anemia: a review of the roentgenographic findings in the skeleton: Hickey lecture, 1957. , 1957, The American journal of roentgenology, radium therapy, and nuclear medicine.

[9]  R. V. van Oers,et al.  Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. , 1994, Blood.

[10]  L. Aarden,et al.  Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop. , 1996, The Journal of clinical investigation.

[11]  K. Abromeit Music Received , 2023, Notes.

[12]  P. Roberson,et al.  Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption. , 1998, The Journal of clinical investigation.

[13]  R. Jilka,et al.  Cytokines, bone remodeling, and estrogen deficiency: a 1998 update. , 1998, Bone.

[14]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[15]  I. Hammel,et al.  Osteopenia, hematopoiesis, and bone remodelling in iliac crest and femoral biopsies: a prospective study of 102 cases of femoral neck fractures. , 1991, Bone.

[16]  T. Martin,et al.  Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. , 1999, Bone.

[17]  A. Parfitt The Bone Remodeling Compartment: A Circulatory Function for Bone Lining Cells , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  S. C. Lin,et al.  Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. , 1997, The Journal of clinical investigation.

[19]  N. Tatsumi,et al.  Thrombopoietin inhibits in vitro osteoclastogenesis from murine bone marrow cells. , 1997, Endocrinology.

[20]  K. Bendix,et al.  A histomorphometric study of haematological disorders with respect to marrow fibrosis and osteosclerosis , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[21]  R. Pacifici Aging and Cytokine Production , 1999, Calcified Tissue International.

[22]  K Yano,et al.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  H. Poulsen,et al.  Transforming growth factor and cancer , 1995 .

[24]  L. Sedel,et al.  Bone resorption at the femoral neck is dependent on local factors in nonosteoporotic late postmenopausal women: An in vitro‐in vivo study , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  Richard L. P. Custer,et al.  An Atlas of the Blood and Bone Marrow , 1974 .

[26]  D. Lacey,et al.  A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. , 1996, Blood.

[27]  T. Guise,et al.  Cancer and bone. , 1998, Endocrine reviews.

[28]  L. Ashman,et al.  Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1). , 1994, The Journal of investigative dermatology.

[29]  R. Van Tiggelen,et al.  Gaucher disease , 2019, Haematology.

[30]  K. Mann,et al.  Characterization of human osteoblast and megakaryocyte-derived osteonectin (SPARC). , 1992, Blood.

[31]  K. Aoki,et al.  Humoral Hypercalcemia of Malignancy with Elevated Plasma PTHrP, TNFα and IL‐6 in Cutaneous Squamous Cell Carcinoma , 1996, The Journal of dermatology.

[32]  J. Compston,et al.  Bone Remodeling and Structure in Postmenopausal Women Treated with Long-Term, High-Dose Estrogen Therapy , 1999, Osteoporosis International.

[33]  E. Puscheck,et al.  Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Pavone,et al.  Extraordinary intrathecal bone reaction in β-thalassaemia intermedia , 1999, The Lancet.

[35]  P. Meltzer,et al.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.

[36]  J. Wysolmerski,et al.  Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein. , 1994, Annual review of medicine.

[37]  K. Yamazaki,et al.  A study of intercellular relationships between trabecular bone and marrow stromal cells in the murine femoral metaphysis , 1995, Anatomy and Embryology.

[38]  P. Genever,et al.  Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. , 1999, Blood.

[39]  T. Martin,et al.  The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures , 1996, The Journal of experimental medicine.

[40]  J. Compston,et al.  Sex steroids and bone. , 2001, Physiological reviews.

[41]  R. Kitazawa,et al.  Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. , 1994, The Journal of clinical investigation.

[42]  J. Compston,et al.  Colocalization of Glucocorticoid and Mineralocorticoid Receptors in Human Bone , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[44]  J. Compston,et al.  Tie2 ligands angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone. , 2001, Bone.

[45]  P. Lansdorp,et al.  Production of interleukin-1 by bone marrow myeloma cells. , 1989, Blood.

[46]  A. Parfitt Osteoclast precursors as leukocytes: importance of the area code. , 1998, Bone.

[47]  L Berga,et al.  Age-related variations of fat tissue fraction in normal human bone marrow depend both on size and number of adipocytes: a stereological study. , 1989, Experimental hematology.

[48]  R. Jilka,et al.  Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. , 1995, The New England journal of medicine.

[49]  T. Martin,et al.  Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors , 1995, The Journal of experimental medicine.

[50]  Flemming Melsen,et al.  Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[51]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[52]  J. Compston,et al.  The localization of androgen receptors in human bone. , 1997, The Journal of clinical endocrinology and metabolism.

[53]  E. Vichinsky,et al.  Bone disease in β-thalassaemia , 1999, The Lancet.

[54]  J O McGee,et al.  The human osteoclast precursor circulates in the monocyte fraction. , 1996, Endocrinology.

[55]  L. Diggs,et al.  Bone and Joint Lesions in Sickle‐Cell Disease , 1967, Clinical orthopaedics and related research.

[56]  J. Compston,et al.  Estrogen Receptors α and β Are Differentially Expressed in Developing Human Bone1 , 2001 .

[57]  S. Ralston,et al.  Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[58]  D. Dyke Similarity in Distribution of Skeletal Blood Flow and Erythropoietic Marrow , 1967 .

[59]  P Meunier,et al.  Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. , 1971, Clinical orthopaedics and related research.

[60]  S. Manolagas,et al.  Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy. , 1997, Endocrinology.

[61]  S. Teitelbaum,et al.  Bone resorption by osteoclasts. , 2000, Science.

[62]  R. Thompson,et al.  Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. , 1994, The Journal of clinical investigation.

[63]  D. Purdie,et al.  The effect of long term oestradiol implantation on bone mineral density in postmenopausal women who have undergone hysterectomy and bilateral oophorectomy , 1997, British journal of obstetrics and gynaecology.

[64]  H. Asaoku,et al.  Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma. , 1989, Blood.

[65]  J. Compston,et al.  The expression of thyroid hormone receptors in human bone. , 1996, Bone.

[66]  J. Glowacki,et al.  Expression of an Extracellular Calcium‐Sensing Receptor in Human and Mouse Bone Marrow Cells , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.